Fulgent Genetics has seen two of its top executives sell shares to cover tax obligations related to the vesting of restricted stock units.
Gao Hanlin, the company’s Chief Scientific Officer, sold 1,063 shares of common stock on September 3, 2025, at a weighted-average price of $22.0267 per share, totaling $23,414. Following this transaction, Hanlin directly owns 957,085 shares of Fulgent Genetics.
Xie Jian, President and COO of Fulgent Genetics, sold 1,128 shares of Common Stock on the same date, with each share priced at the same weighted-average of $22.0267, resulting in a total sale amount of $24,846. After the sale, Jian directly owns 364,121 shares and indirectly owns 220,816 shares through The Hsieh Family Dynasty Trust.